PK Biosciences was founded in 2006 and located in Ames, IA. We are developing innovative medicines that are targeted against selective PKC isoforms. These are involved in the apoptotic cell death pathway, observed in many neurodegenerative disorders.

PK Biosciences Corporation is a private company.

For all enquiries, please contact, the President of  our company, Dr. Anumantha G Kanthasamy. Email: kant@pkbio.com